EMA approves vaginal ring for HIV prevention

preview_player
Показать описание
The European Medicines Agency has approved the Vaginal Ring for HIV prevention for women in non-EU countries with high disease burdens. The antiretroviral drug dapivirine is released from the ring into the vagina slowly over one month. #eNCA talks to Zeda Rosenberg, CEO of the International Partnership for Microbicides. Courtesy #DStv403
  1. eNCA
Рекомендации по теме
EMA approves vaginal 0:06:21

EMA approves vaginal ring for HIV prevention

Understanding the EMA 1:17:50

Understanding the EMA Opinion: Next Steps for Dapivirine Vaginal Ring

Vaginal ring - 0:16:28

Vaginal ring - Dr Zeda Rosenberg

FDA approves Vaginal 0:05:01

FDA approves Vaginal ring contraceptive Annovera

2020 09 24 1:30:11

2020 09 24 | The Dapivirine Vaginal Ring

Your Health: WHO 0:24:35

Your Health: WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women

IAS 2021: Dr 0:01:35

IAS 2021: Dr Lulu Nair talks about vaginal rings and oral PrEP

🔴 WEBINAR | 1:00:43

🔴 WEBINAR | European Medicines Agency Regulatory approach to COVID 19 vaccines therapeutics

Real Voices in 0:02:20

Real Voices in Women's HIV Prevention: Episode 3

SCOPE Community e-meeting: 1:43:21

SCOPE Community e-meeting: Developments in PrEP Implementation Issues

Zimbabwe shows how 0:06:19

Zimbabwe shows how to make new HIV prevention products available quickly / hivaids

Women's Health and 0:03:13

Women's Health and HIV

A Conversation On 0:56:04

A Conversation On the Dapivirine Ring- What do the WHO Guidelines Mean for Access?

Microbicides: Developing New 0:06:02

Microbicides: Developing New HIV Prevention Options for Women

STEP-UP 2020-2021: Video 1:56:10

STEP-UP 2020-2021: Video 6 – Prevention biomedical research

HIV Prevention Studies 0:28:11

HIV Prevention Studies and Newer Technologies - Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD

Challenges and Opportunities 0:36:15

Challenges and Opportunities for Preexposure Prophylaxis

CFAR Seminar: Sharon 0:59:13

CFAR Seminar: Sharon Hillier, PhD- Developing Options to Improve Choices in HIV Prevention, Sept2020

Challenges and Opportunities 0:36:15

Challenges and Opportunities for Preexposure Prophylaxis

E-meeting: Developments in 1:25:05

E-meeting: Developments in the HIV prevention pipeline: PrEP, vaccines and more

Ch 10.7 Human 0:12:22

Ch 10.7 Human Sexuality Spermicides

Advances in Medical 0:30:13

Advances in Medical Options for Uterine Fibroids and Endometriosis

Long term impacts 0:16:40

Long term impacts of PrEP – How to reduce toxicity and resistance - Pep Coll, MD

HIV Prevention in 0:19:27

HIV Prevention in High Risk Populations: Unique Challenges and Solutions - Jean-Michel Molina